Cellestis Report issue

For profit Phase 4
Founded: Santa Clarita CA United States (2001)
Status: Acquired by Qiagen (2011) → now Thermo Fisher Scientific (2020)

Organization Overview

First Clinical Trial
2010
NCT01223534
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree